Active, Teva's laquinimod misses in Phase II for HD

Active Biotech AB (SSE:ACTI) said once-daily 1 mg oral laquinimod missed the primary endpoint

Read the full 146 word article

How to gain access

Continue reading with a
two-week free trial.